Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    1952493 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Replacement GH Therapy After Bariatric Surgery in Patients With Very Severe Obesity
Conditions: Obesity;   GHD
Intervention: Drug: Recombinant GH Saizen (Merck-Serono)

Indicates status has not been verified in more than two years